findmyKOL
Clinical trialNCT06222580RecruitingPhase 1Interventional

SNDX-5613 and Gilteritinib for the Treatment of Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia and Concurrent MLL-Rearrangement or NPM1 Mutation

SponsorUma BorateEnrollment30Acute Myeloid Leukemia With FLT3/ITD MutationAcute Myeloid Leukemia With KMT2A RearrangementAcute Myeloid Leukemia With NPM1 MutationRecurrent Acute Myeloid LeukemiaRefractory Acute Myeloid Leukemia
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Unc Hospitals, University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina, United States

    Joshua F Zeidner, MD
    Recruiting
  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

    Uma M. Borate, MD, MS
    Recruiting
  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

    Alexander Perl, MD
    Recruiting
  • University of Wisconsin Carbone Cancer Center

    Madison, Wisconsin, United States

    Kieran Sahasrabudhe, MD
    Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Feb 2024
Primary completion
31 Jan 2027
Completion
28 Feb 2027
Last update posted
14 May 2026
Registered enrollment
30
Registry id
NCT06222580
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.